WHO approves another Chinese vaccine 'Sinovac', this vaccine meets international standards
The WHO on Tuesday approved the Sinovac-Coronavac COVID-19 vaccine for emergency use. The vaccine meets international standards in terms of safety, efficacy and formulation. The vaccine is made by Beijing-based pharmaceutical company Sinovac.
The World Health Organization (WHO) said on Tuesday that it has approved China's second Covid-19 vaccine 'Sinovac' for inclusion in the emergency use list.
Sinovac-Coronavac Covid-19 vaccine approved, Beijing-based pharmaceutical company Sinovac
The UN health agency said in a statement that the WHO on Tuesday approved the Sinovac-Coronavac COVID-19 vaccine for emergency use. Countries, procurement agencies and communities have been assured that the vaccine meets international standards for safety, efficacy and formulation. The vaccine is made by Beijing-based pharmaceutical company Sinovac.
Simao said – the world desperately needs many corona vaccines
WHO Assistant Director-General Dr. Mariangela Simao said that the world is in dire need of many corona vaccines. We urge manufacturers to participate in the Kovax programme, share their knowledge and data and contribute towards bringing the pandemic under control. The WHO on May 7 gave conditional approval to China's Sinoform Covid-19 vaccine for emergency use.
WHO names virus found in India as 'Delta' and 'Kappa'
The B.1.617.2 variant of the corona virus found for the first time in India has been given a new name. The World Health Organization has said that B.1.617.2 will be known as Delta, while another variant found here, B.1.617.1, has been named Kappa. These forms of corona were first identified in India in October 2020.
B.1.617.2 Strong objection to the Government of India being called the Indian variant
The WHO has also named the variants found in other countries of the world based on the Greek alphabets. This decision has come at a time when there was a dispute about associating different variants of Corona with the names of countries. The Government of India had strongly objected to B.1.617.2 being called the Indian variant.